Lv3
294 积分 2023-06-05 加入
Two-decade trajectories of gout: a multicentre cohort study of 10 658 Chinese patients with gout
15小时前
待确认
Immune and inflammatory mechanisms and therapeutic targets of gout: An update
16小时前
已完结
EGFR-TKIs plus bevacizumab demonstrated survival benefit than EGFR-TKIs alone in patients with EGFR-mutant NSCLC and multiple brain metastases
4天前
已完结
Immune and inflammatory mechanisms and therapeutic targets of gout: An update
4天前
已完结
GOUT
4天前
已关闭
A phase II, multicenter, two cohort study of 160 mg osimertinib in EGFR T790M-positive non-small-cell lung cancer patients with brain metastases or leptomeningeal disease who progressed on prior EGFR TKI therapy
5天前
已完结
Treatment for Brain Metastases: ASCO-SNO-ASTRO Guideline
5天前
已完结
Brain Metastases in EGFR- and ALK-Positive NSCLC: Outcomes of Central Nervous System-Penetrant Tyrosine Kinase Inhibitors Alone Versus in Combination With Radiation
6天前
已完结
Clinical Value of Upfront Cranial Radiation Therapy in Osimertinib-Treated Epidermal Growth Factor Receptor–Mutant Non-Small Cell Lung Cancer With Brain Metastases
6天前
已完结
Gout
10天前
已关闭
皖公网安备34019202002308
